SIERRA ONCOLOGY INC's ticker is SRRA and the CUSIP is 82640U404. A total of 74 filers reported holding SIERRA ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.17 and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $331,000 | -14.7% | 10,321 | -42.2% | 0.02% | +28.6% |
| Q4 2021 | $388,000 | -82.7% | 17,856 | -87.3% | 0.01% | -86.8% |
| Q4 2020 | $2,247,000 | +50.3% | 140,156 | 0.0% | 0.11% | -2.8% |
| Q3 2020 | $1,495,000 | -11.9% | 140,156 | 0.0% | 0.11% | -19.9% |
| Q2 2020 | $1,696,000 | -38.4% | 140,156 | -50.0% | 0.14% | -16.0% |
| Q1 2020 | $2,752,000 | – | 280,312 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 643,959 | $10,323,000 | 6.44% |
| Vivo Capital, LLC | 1,917,074 | $30,731,000 | 1.37% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 135,000 | $2,164,000 | 1.26% |
| Ghost Tree Capital, LLC | 200,000 | $3,206,000 | 0.71% |
| Telemetry Investments, L.L.C. | 22,349 | $358,000 | 0.60% |
| FRAZIER MANAGEMENT LLC | 202,803 | $3,251,000 | 0.25% |
| MANGROVE PARTNERS IM, LLC | 108,914 | $1,746,000 | 0.24% |
| Ikarian Capital, LLC | 318,890 | $5,111,000 | 0.22% |
| Sio Capital Management, LLC | 66,455 | $1,065,000 | 0.22% |
| Orbimed Advisors | 1,477,320 | $23,681,000 | 0.21% |